We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Alnylam Pharmaceuticals Inc | NASDAQ:ALNY | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 147.36 | 141.00 | 155.48 | 0 | 12:01:04 |
Alnylam Pharmaceuticals, Inc.
|
Delaware
|
001-36407
|
77-0602661
|
(State or Other Juris-
diction of Incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
300 Third Street, Cambridge, MA
|
02142
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Not applicable
|
(Former Name or Former Address, if Changed Since Last Report)
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
||
Common Stock, $0.01 par value per share
|
ALNY
|
The Nasdaq Stock Market LLC
|
Item 2.02.
|
Results of Operations and Financial Condition
|
Item 9.01.
|
Financial Statements and Exhibits
|
Date: August 6, 2019
|
ALNYLAM PHARMACEUTICALS, INC.
|
|
By:
|
/s/ Manmeet S. Soni
|
|
Manmeet S. Soni
|
||
Senior Vice President, Chief Financial Officer
|
1 Year Alnylam Pharmaceuticals Chart |
1 Month Alnylam Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions